Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Financial results for Quarter and Financial Year ended on 31 March 2025.more...
Appointment of Mr. Yogainder Kumar Gupta (DIN:03094998) as Additional Director Non-executive Independent Director on the Board of Directors of the Co...more...
1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2025....more...
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to conside...more...
As of March 2025 46.78% is owned by Indian Promoters and 53.22% by Public. Top two Promoters holding highest number of shares of Genomic Val...more...
Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st March 2025.more...
Please find enclosed herewith the Integrated Filing (Financial) for the Quarter and Nine Months ended 31st December 2024more...
Please find enclosed herewith the Financial Results for Quarter and Nine months ended 31st December 2024 pursuant to Regualation 33 of SEBI (Listing ...more...
Outcome of the Board Meeting pursuant to Regulation 30 held today i.e. 14th February 2025 read with Regulation 33 of SEBI (Listing Obligatio...more...
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to conside...more...
As of December 2024 46.83% is owned by Indian Promoters and 53.17% by Public. Top two Promoters holding highest number of shares of Genomic ...more...
Please find enclosed herewith Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation...more...
Resignation of Independent Director of the Companymore...
Submission of Voting Results of 30th Annual General Meeting Of The Company Under Regulation 44(3) Of the SEBI Listing Obligations & disclosure Requir...more...
Submission of Voting Results of 30th Annual General Meeting Of The Company Under Regulation 44(3) Of the SEBI Listing Obligations & disclosu...more...
Please Find enclosed herewith copy of proceeding of the 30th Annual General Meeting of the Company for your reference.more...
Enter Stock
BOARD MEETINGS Company Name : Bampsl Securitie Date : 21-06-2025